SEC Form 4 · accession 0001104659-16-129537
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Alan Joslyn
Director
Period of report
Jun 24, 2016
Accepted (ET)
Jun 27, 2016 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $3.67 | Jun 24, 2016 | A | 62,500 | A | — | Jun 24, 2026 | Common Stock | 62,500 | 259,020 | D |
Explanation of responses
- F120,833 of the options vest on each of 6/24/2017 and 2018 and 20,834 vest on 6/24/2019.